Cargando…
Ulinastatin Reduces the Resistance of Liver Cancer Cells to Epirubicin by Inhibiting Autophagy
During chemotherapy, drug resistance caused by autophagy remains a major challenge to successful treatment of cancer patients. The purpose of this study is to show that ulinastatin (UTI), a trypsin inhibitor, could reduce the resistance of liver cancer cells to chemotherapeutic agent epirubicin (EPI...
Autores principales: | Song, Bin, Bian, Qi, Shao, Cheng Hao, Li, Gang, Liu, An An, Jing, Wei, Liu, Rui, Zhang, Yi-Jie, Zhou, Ying-Qi, Hu, Xian-Gui, Jin, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376693/ https://www.ncbi.nlm.nih.gov/pubmed/25815885 http://dx.doi.org/10.1371/journal.pone.0120694 |
Ejemplares similares
-
Downregulation of ASPP2 in pancreatic cancer cells contributes to increased resistance to gemcitabine through autophagy activation
por: Song, Bin, et al.
Publicado: (2015) -
Ulinastatin attenuates lipopolysaccharide-induced cardiac dysfunction by inhibiting inflammation and regulating autophagy
por: Zhao, Pin, et al.
Publicado: (2020) -
Effects of Ulinastatin on Proliferation and Apoptosis of Breast Cancer Cells by Inhibiting the ERK Signaling Pathway
por: Xing, Zeyu, et al.
Publicado: (2021) -
Inhibiting autophagy increases epirubicin's cytotoxicity in breast cancer cells
por: Guo, Wei, et al.
Publicado: (2016) -
Nanostructured Dihydroartemisinin Plus Epirubicin Liposomes Enhance Treatment Efficacy of Breast Cancer by Inducing Autophagy and Apoptosis
por: Hu, Ying-Jie, et al.
Publicado: (2018)